Rational use management standards of national key monitoring drug

XU Feifei; BIAN Yuan; HAN Yong; YAN Junfeng; TONG Rongsheng

doi:10.6039/j.issn.1001-0408.2023.19.01

您当前的位置：

首页 >

文章列表页 >

Rational use management standards of national key monitoring drug

更新时间：2025-09-26

- Rational use management standards of national key monitoring drug
- ZHONGGUO YAOFANG Vol. 34, Issue 19, Pages: 2305-2310(2023)
- 作者机构：
  
  1.四川省医学科学院·四川省人民医院药学部，成都　610072
  2.电子科技大学医学院个体化药物治疗四川省重点实验室，成都　610072
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2023.19.01
  CLC： R95
- Received：30 July 2023，
  
  Revised：2023-08-14，
  
  Accepted：14 August 2023，
  
  Published：15 October 2023
- 稿件说明：
移动端阅览
徐菲飞,边原,韩勇,等.国家重点监控药品合理用药管理规范[J].中国药房,2023,34(19):2305-2310.

XU Feifei,BIAN Yuan,HAN Yong,et al.Rational use management standards of national key monitoring drug[J].ZHONGGUO YAOFANG,2023,34(19):2305-2310.
徐菲飞,边原,韩勇,等.国家重点监控药品合理用药管理规范[J].中国药房,2023,34(19):2305-2310. DOI： 10.6039/j.issn.1001-0408.2023.19.01.

XU Feifei,BIAN Yuan,HAN Yong,et al.Rational use management standards of national key monitoring drug[J].ZHONGGUO YAOFANG,2023,34(19):2305-2310. DOI： 10.6039/j.issn.1001-0408.2023.19.01.

摘要

目前，国家重点监控药品的合理使用管理缺乏统一的规范。为使国家重点监控药品在各级医疗机构更加合理使用和规范管理，根据国家的相关要求和近年来国内外发布的相关文献，并结合全国多家医疗机构对国家重点监控药品的管理实践，由中华医学会临床药学分会、中国药学会药物流行病学专委会及四川省药学会药物流行病学专委会组织专家充分讨论，形成《国家重点监控药品合理用药管理规范》。本规范主要内容包括重点监控药品的合理使用基本原则及重点监控药品监管办法，特别是怎样加强重点监控药品的药事管理和使用管理，旨在推动重点监控药品的规范使用，促进合理用药。

Abstract

At present， there is a lack of unified and standardized management for the rational use of national key monitoring drugs. According to the relevant requirements of the state， based on the relevant literature published at home and abroad in recent years and combined with the management practice of many medical institutions across the country on the national key monitoring drugs， in order to make the national key monitoring drugs more reasonable use and standardized management in medical institutions at all levels， the Clinical Pharmacy Branch of the Chinese Medical Association， the Pharmaceutical Epidemiology Special Committee of the Chinese Pharmaceutical Association and the Pharmaceutical Epidemiology Special Committee of the Sichuan Pharmaceutical Association organized experts to fully discuss， and to form this management standard. This standard mainly provides relevant opinions and suggestions on the basic principles of rational use of key monitoring drugs and the regulatory measures for key monitoring drugs， especially on how to strengthen the pharmaceutical management and use management of key monitoring drugs， further promoting the standardized use of key monitoring drugs.

关键词

Keywords

references

国家卫生健康委员会医政医管局 . 《关于印发国家重点监控合理用药药品目录调整工作规程的通知》解读 [EB/OL ] .[ 2023-05-11 ] . http：//www.nhc.gov.cn/yzygj/s7659/202109/5162329bf12d40ea9327b4e8db5103dc.shtml http://www.nhc.gov.cn/yzygj/s7659/202109/5162329bf12d40ea9327b4e8db5103dc.shtml .

Medical Administration Bureau of the National Health Commission . Interpretation of the notice on printing and distributing the work procedures for adjusting the drug catalogue of national key monitoring and reasonable drug use [EB/OL ] .[ 2023-05-11 ] . http：//www.nhc.gov.cn/yzygj/s7659/202109/5162329bf12d40ea9327b4e8db5103dc.shtml http://www.nhc.gov.cn/yzygj/s7659/202109/5162329bf12d40ea9327b4e8db5103dc.shtml .

王笛，王相峰，毛丽超，等 . 我国医疗机构重点监控药品监测平台合理应用管理指标的探讨 [J ] . 中国药房， 2021 ， 32 （ 8 ）： 911 - 914 .

WANG D ， WANG X F ， MAO L C ， et al . Discussion on the rational application of management indicators for key monitoring drug monitoring platforms in medical institutions in China [J ] . China Pharm ， 2021 ， 32 （ 8 ）： 911 - 914 .

黎赛，盛小燕，梁椅文，等 . 我院重点监控药品管理实践和干预措施探讨 [J ] . 中国药房， 2018 ， 29 （ 22 ）： 3029 - 3034 .

LI S ， SHENG X Y ， LIANG Y W ， et al . Exploration of key surveillance drug management practices and intervention measures in our hospital [J ] . China Pharm ， 2018 ， 29 （ 22 ）： 3029 - 3034 .

国家卫生健康委员会医政医管局 . 关于进一步加强用药安全管理提升合理用药水平的通知 [EB/OL ] .[ 2023-05-11 ] . http：//www.nhc.gov.cn/yzygj/s7659/202207/007020b-813ce446ba3cab3258775270a.shtml http://www.nhc.gov.cn/yzygj/s7659/202207/007020b-813ce446ba3cab3258775270a.shtml .

Medical Administration Bureau of the National Health Commission . Notice on further strengthening drug safety management and improving the level of reasonable drug use [EB/OL ] .[ 2023-05-11 ] . http：//www.nhc.gov.cn/yzygj/s7659/202207/007020b813ce446ba3cab3258775270a.shtml http://www.nhc.gov.cn/yzygj/s7659/202207/007020b813ce446ba3cab3258775270a.shtml .

国家卫生健康委员会医政医管局 . 国家卫生健康委办公厅关于印发国家重点监控合理用药药品目录调整工作规程的通知 [EB/OL ] .[ 2023-05-11 ] . http：//www.nhc.gov.cn/yzygj/s7659/202109/a91498010ba74db5a752fb1b12d21-b98.shtml http://www.nhc.gov.cn/yzygj/s7659/202109/a91498010ba74db5a752fb1b12d21-b98.shtml .

Medical Administration Bureau of the National Health Commission . Notice of the General Office of the National Health Commission on issuing the work procedures for adjusting the drug catalogue of national key monitoring and reasonable drug use [EB/OL ] .[ 2023-05-11 ] . http：//www.nhc.gov.cn/yzygj/s7659/202109/a91498010ba74db5a752-fb1b12d21b98.shtml http://www.nhc.gov.cn/yzygj/s7659/202109/a91498010ba74db5a752-fb1b12d21b98.shtml .

国家卫生健康委办公厅 . 国家卫生健康委办公厅关于印发第二批国家重点监控合理用药药品目录的通知 [EB/OL ] .[ 2023-01-13 ] . http：//www.nhc.gov.cn/xcs/zhengcwj/202301/5b291aaae64b4e56a10f9ea910e11426.shtml http://www.nhc.gov.cn/xcs/zhengcwj/202301/5b291aaae64b4e56a10f9ea910e11426.shtml .

General Office of the National Health Commission . Notice of the General Office of the National Health Commission on issuing the second batch of national key monitoring and reasonable drug use catalogue [EB/OL ] .[ 2023-01-13 ] . http：//www.nhc.gov.cn/xcs/zhengcwj/202301/5b291aaae-64b4e56a10f9ea910e11426.shtml http://www.nhc.gov.cn/xcs/zhengcwj/202301/5b291aaae-64b4e56a10f9ea910e11426.shtml .

国家卫生健康委办公厅 . 国家卫生健康委办公厅关于印发新型抗肿瘤药物临床应用指导原则（2021年版）的通知 [EB/OL ] .[ 2023-05-11 ] . http：//www.nhc.gov.cn/yzygj/s7659/202112/0fbf3f04092b4d67be3b3e89040d8489.shtml http://www.nhc.gov.cn/yzygj/s7659/202112/0fbf3f04092b4d67be3b3e89040d8489.shtml .

General Office of the National Health Commission . Notice of the General Office of the National Health Commission on issuing the guiding principles for the clinical application of new antitumor drugs （2021 edition） [EB/OL ] .[ 2023-05-11 ] . http：//www.nhc.gov.cn/yzygj/s7659/202112/0fbf3f04092b4d67be3b3e89040d8489.shtml http://www.nhc.gov.cn/yzygj/s7659/202112/0fbf3f04092b4d67be3b3e89040d8489.shtml .

Views

510

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

National Key Monitoring Drug Rational Use Management Standards

Pharmaceutical care for toxic epidermal necrolysis in patients with deep vein thrombosis and acute renal insufficiency induced by warfarin

Prospective cohort study on clinical pharmacist involvement in the management of opioid use after orthopedic surgery under the enhanced recovery after surgery model

One case report and literature review of severe cardiotoxicity by oxaliplatin combined with capecitabine

Pharmaceutical care in a patient with hemorrhagic transformation after cerebral infarction complicated with atrial fibrillation

Related Author

XU Feifei

BIAN Yuan

HAN Yong

YAN Junfeng

TONG Rongsheng

SHI Chao

SHU Dezhong

YANG Yumin

Related Institution

Department of Pharmacy， Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital， School of Medicine， University of Electronic Science and Technology of China

Personalized Drug Therapy Key Laboratory of Sichuan Province， School of Medicine， University of Electronic Science and Technology of China

Dept. of Pharmacy， Fuling Hospital Affiliated to Chongqing University

Dept.of Pharmacy， Baoding No.1 Central Hospital

Dept. of Pharmacy， Medical Supplies Center， Chinese PLA General Hospital

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰